Cargando…
Tocilizumab Treatment for Takayasu Arteritis in Pregnancy: A Case Report With Positive Maternal and Neonatal Outcomes
Takayasu arteritis (TAK) is a rare vasculitis that often affects young women of childbearing age, and its management during pregnancy poses unique challenges. Limited data exist regarding the safety and efficacy of tocilizumab (TCZ), an interleukin-6 receptor antagonist, in the treatment of TAK duri...
Autores principales: | Sugisaki, Kota, Sakauchi, Michihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10181295/ https://www.ncbi.nlm.nih.gov/pubmed/37188300 http://dx.doi.org/10.14740/jmc4083 |
Ejemplares similares
-
Tocilizumab for faster and safer remission of Takayasu’s arteritis
por: Liao, Hua, et al.
Publicado: (2022) -
A successful antenatal outcome in a patient with refractory Takayasu’s arteritis treated with tocilizumab throughout pregnancy—a case report
por: Khan, Behram, et al.
Publicado: (2023) -
Utility and safety of tocilizumab in Takayasu arteritis with severe heart failure and muscle wasting
por: Yano, Toshiyuki, et al.
Publicado: (2019) -
Effectiveness of Tocilizumab in juvenile patients with refractory Takayasu arteritis: Two case reports
por: Asano, Tomoyuki, et al.
Publicado: (2020) -
Takayasu’s Arteritis in Pregnancy: Challenges During the Ongoing Coronavirus Disease 2019 Pandemic for Optimal Maternal and Neonatal Outcomes
por: Singh, Sweta, et al.
Publicado: (2020)